Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd announces launch of Sumatriptan Injection USP, autoinjector systemi


Wednesday, 26 Feb 2014 12:43am EST 

Dr.Reddy's Laboratories Ltd:Has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL For Subcutaneous Use.Says injection was launched In the US market on Feb. 25, 2014, following the approval by the United States Food & Drug Administration. 

Company Quote

3390.05
9.1 +0.27%
1:09am EDT